Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray

American Journal of Pathology

Volumn 162, Issue 3, 2003, Pages 925-932

  Higgins, John P T ^a   Shinghal, Rajesh ^a   Gill, Harcharan ^a   Reese, Jeffrey H ^b   Terris, Martha ^c   Cohen, Ronald J ^d   Fero, Michael ^a   Pollack, Jonathan R ^a   Van de Rijn, Matt ^a   Brooks, James D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENTARY DNA; KERATIN; VIMENTIN;

ANGIOMYOLIPOMA; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DNA DETERMINATION; DNA MICROARRAY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TUMOR CLASSIFICATION;

EID: 0344127560     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63887-4     Document Type: Article

References (44)

1. Godley PA, Escobar MA: Renal cell carcinoma. Curr Opin Oncol 1998, 10:261-265
2. McLaughlin JK, Lipworth L: Epidemiologic aspects of renal cell cancer. Semin Oncol 2000, 27:115-123
3. Franklin JR, Figlin R, Belldegrun A: Renal cell carcinoma: basic biology and clinical behavior. Semin Urol Oncol 1996, 14:208-215
4. Couillard DR, DeVere White RW: Surgery of renal cell carcinoma. Urol Clin North Am 1993, 20:263-275
5. Yagoda A, Abi-Rached B, Petrylak D: Chemotherapy for advanced renal cell carcinoma: 1983-1993. Semin Oncol 1995, 22:42-60
6. Thrasher JB, Paulson DF: Prognostic factors in renal cancer. Urol Clin North Am 1993, 20:247-262
7. Strohmeyer T, Ackermann R: Classic and modern prognostic indicators in renal cell carcinoma: review of the literature. Urol Int 1991, 47:203-212
8. Reese JH: Renal cell carcinoma. Curr Opin Oncol 1992, 4:427-434
9. Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M: Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002, 26:281-291
10. Zhao WP, Gnarra JR, Liu S, Knutsen T, Linehan WM, Whang-Peng J: Renal cell carcinoma: cytogenetic analysis of tumors and cell lines. Cancer Genet Cytogenet 1995, 82:128-139
11. Kovacs G, Fuzesi L, Emanual A, Kung HF: Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 1991, 3:249-255
12. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ: The Heidelberg classification of renal cell tumours. J Pathol 1997, 183:131-133
13. Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS: Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 2001, 158:1639-1651
14. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K: Classification of renal cell carcinoma: workgroup no. 1; Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997, 80:987-989
15. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868
16. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511
17. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA: Molecular portraits of human breast tumours. Nature 2000, 406:747-752
18. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, lyer V, Jeffrey SS, Van de Rijn M, Waltham M: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227-235
19. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121
20. Higgins JP, Warnke RA: CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 1999, 112:241-247
21. lyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY: Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 α. Genes Dev 1998, 12:149-162
22. Hu J, Discher DJ, Bishopric NH, Webster KA: Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 1998, 245:894-899
23. Feldser D, Agani F, lyer NV, Pak B, Ferreira G, Semenza GL: Reciprocal positive regulation of hypoxia-inducible factor 1 α and insulin-like growth factor 2. Cancer Res 1999, 59:3915-3918
24. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275
25. Clifford SC, Maher ER: Von Hippel-Lindau disease: clinical and molecular perspectives. Adv Cancer Res 2001, 82:85-105
26. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ: α-Methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002, 62:2220-2226
27. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM: α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002, 287:1662-1670
28. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M: CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998, 11:728-734
29. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR: Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002, 359:1301-1307
30. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, Lydon NB: Abl protein-tyrosine kinase inhibitor ST1571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000, 295:139-145
31. Skinnider BF, Jones EC: Renal oncocytoma and chromophobe renal cell carcinoma: a comparison of colloidal iron staining and electron microscopy. Am J Clin Pathol 1999, 111:796-803
32. Tickoo SK, Lee MW, Eble JN, Amin M, Christopherson T, Zarbo RJ, Amin MB: Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol 2000, 24:1247-1256
33. Akhtar M, Kardar H, Linjawi T, McClintock J, Ali MA: Chromophobe cell carcinoma of the kidney: a clinicopathologic study of 21 cases. Am J Surg Pathol 1995, 19:1245-1256
34. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537
35. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001, 98:13784-13789
36. Martignoni G, Pea M, Chilosi M, Brunelli M, Scarpa A, Colato C, Tardanico R, Zamboni G, Bonetti F: Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 2001, 14:760-767
37. Markovic-Lipkovski J, Brasanac D, Todorovic V, Muller CA, Muller GA: Immunomorphological characteristics of renal cell carcinoma. Histol Histopathol 1995, 10:651-659
38. Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, Walther M, Choyke P, Weirich G, Hewitt SM: Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomarkers Prev 2002, 11:393-400
39. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, Teh BT: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 2001, 98:9754-9759
40. Boer JM, Huber WK, Sultmann H, Wilmer F, von Heydebreck A, Haas S, Korn B, Grunawan B, Vente A, Fuzesi L, Vingron M, Poustka A: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 2001, 11:1861-1870
41. Belbin TJ, Singh B, Barber I, Socci N, Wenig B, Smith R, Prystowsky MB, Childs G: Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2002, 62:1184-1190
42. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 1:133-143
43. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG: Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1:75-87
44. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002, 30:41-47